Beginnings of Personalized Medicine for Myeloma
Video Categories: Personalized Medicine
Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.
April 14, 2015
Description: Dr. Boccia describes cases in which he uses CancerTREATMENT NGS+ in his clinical practice.
January 20, 2016
Dr Wainberg and Dr Gerson discuss how biomarkers may help identify cancer stem cells.